Recordati UK clinical trials
Acquired by RECORDATI GROUP, Mar 16, 2022 · source ↗
The registry lists 2 studies whose lead sponsor is Recordati UK. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Apr 19, 2021.
Before and after it joined RECORDATI GROUP
- First submitted before Recordati UK became part of RECORDATI GROUP
- 2
- First submitted after Recordati UK became part of RECORDATI GROUP
- 0
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
Registry sponsor names on this page
- Recordati UK2 studies
Something wrong with this grouping? Tell us on the RECORDATI GROUP page.
Studies
Recruiting first, then most recently updated. Showing 2 of 2. All RECORDATI GROUP studies →
- Siltuximab In Siltuximab-RElapsed/REfractory Multicentric CAstleman DiseaseTerminatedNCT04838860Phase 2
Sponsor listed in the registry: Recordati UK · First submitted before Recordati UK became part of RECORDATI GROUP
- SILtuximab in Viral ARds (SILVAR) StudyTerminatedNCT04616586Phase 3
Sponsor listed in the registry: Recordati UK · First submitted before Recordati UK became part of RECORDATI GROUP